Have a personal or library account? Click to login
Zoonotic Parasitological Findings in a Puppy: The Course and Therapeutical Efficacy Cover

Zoonotic Parasitological Findings in a Puppy: The Course and Therapeutical Efficacy

Open Access
|Jul 2021

Abstract

Considering the close contact of companion animals and humans, gastrointestinal parasitic zoonoses are very widespread and represent a high risk of transmission with the potential of severe consequences affecting the digestive tract of both humans and other animals. In this study we focused on enteric zoonoses caused by Toxocara canis nematode, Dipylidium caninum tapeworm and Giardia duodenalis protozoa. Our primary aim was to observe Toxocara canis egg excretion within the 27 consecutive days before and after orally treatment (2 Caniverm® tablets) on Day 13 in a naturally infected puppy. An average egg per gram (EPG) of T. canis detected by coprological quantitative McMaster method was 4558.33 and 666.66, before and after treatment, respectively. The percentage of faecal egg count reduction (%FECR) in in vivo Faecal Egg Count Reduction Test (FECRT) has confirmed an 85.37 % efficacy against T. canis. Secondly, the efficacy of Caniverm® against the tapeworm Dipylidium caninum was also determined. No D. caninum proglottides were detected on Day 14. The data showed 100 % effectiveness of the anthelmintic treatment. Metrobactin® 250 mg has been tested as experimental therapy against Giardia duodenalis on Day 3. On day 10, no cysts were observed in the faeces after per os ¼ tablet administration twice a day for 7 days.

DOI: https://doi.org/10.2478/fv-2021-0018 | Journal eISSN: 2453-7837 | Journal ISSN: 0015-5748
Language: English
Page range: 58 - 67
Submitted on: Mar 19, 2021
|
Accepted on: May 11, 2021
|
Published on: Jul 12, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 Ľ. Burcáková, G. Štrkolcová, A. Königová, M. Várady, published by The University of Veterinary Medicine and Pharmacy in Košice
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.